Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;88(10):1099-107.
doi: 10.1016/j.mayocp.2013.06.017.

Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system

Affiliations

Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system

John J Sim et al. Mayo Clin Proc. 2013 Oct.

Abstract

Objective: To evaluate the prevalence of and characterize resistant hypertension in a large representative population with successful hypertension management and reliable health information.

Patient and methods: We performed a cross-sectional study using clinical encounter, laboratory, and administrative information from the Kaiser Permanente Southern California health system between January 1, 2006, and December 31, 2007. From individuals older than 17 years with hypertension, resistant hypertension was identified and prevalence was determined. Multivariable logistic regression was used to calculate odds ratios (ORs), with adjustments for demographic characteristics, clinical variables, and medication use.

Results: Of 470,386 hypertensive individuals, 60,327 (12.8%) were identified as having resistant disease, representing 15.3% of those taking medications. Overall, 37,061 patients (7.9%) had uncontrolled hypertension while taking 3 or more medicines. The ORs (95% CIs) for resistant hypertension were greater for black race (1.68 [1.62-1.75]), older age (1.11 [1.10-1.11] for every 5-year increase), male sex (1.06 [1.03-1.10]), and obesity (1.46 [1.42-1.51]). Medication adherence rates were higher in those with resistant hypertension (93% vs 89.8%; P<.001). Chronic kidney disease (OR, 1.84; 95% CI, 1.78-1.90), diabetes mellitus (OR, 1.58; 95% CI, 1.53-1.63), and cardiovascular disease (OR, 1.34; 95% CI, 1.30-1.39) were also associated with higher risk of resistant hypertension.

Conclusion: In a more standardized hypertension treatment environment, we observed a rate of resistant hypertension comparable with that of previous studies using more fragmented data sources. Past observations have been limited due to nonrepresentative populations, reliability of the data, heterogeneity of the treatment environments, and less than ideal control rates. This cohort, which was established using an electronic medical record-based approach, has the potential to provide a better understanding of resistant hypertension and outcomes.

Keywords: BP; CKD; ICD-9; International Classification of Diseases, Ninth Revision; KPSC; Kaiser Permanente Southern California; NHANES; National Health and Nutrition Examination Survey; OR; blood pressure; chronic kidney disease; odds ratio.

PubMed Disclaimer

Conflict of interest statement

Financial Support and Disclosure: No other authors have any conflicts of interest relevant to this manuscript.

Figures

Figure 1
Figure 1
A total of 498,249 subjects were identified with non secondary hypertension which represented 21% of all adults in the KPSC population. Of these, 470,386 subjects with hypertension had at least one documented blood pressure measurement and were included in the study analysis.

References

    1. Kumbhani DJ, Steg PG, Cannon CP, et al. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2012 - PubMed
    1. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–e526. - PubMed
    1. Calhoun DA, Zaman MA, Nishizaka MK. Resistant hypertension. Current hypertension reports. 2002;4:221–228. - PubMed
    1. Cuspidi C, Macca G, Sampieri L, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. Journal of hypertension. 2001;19:2063–2070. - PubMed
    1. Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422–1428. - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts